Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24839 | 299 | 25.9 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
1459 | 2 | BENZODIAZEPINES//ZOLPIDEM//ZOPICLONE | 7774 |
24839 | 1 | N DESMETHYLADINAZOLAM//ADINAZOLAM//SECOND PEAK PLASMA CONCENTRATIONS | 299 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | N DESMETHYLADINAZOLAM | authKW | 408498 | 1% | 100% | 4 |
2 | ADINAZOLAM | authKW | 357429 | 2% | 50% | 7 |
3 | SECOND PEAK PLASMA CONCENTRATIONS | authKW | 204249 | 1% | 100% | 2 |
4 | SIDE EFFECTS DRUG | authKW | 136165 | 1% | 67% | 2 |
5 | ADINAZOLAM DERACYN R | authKW | 102125 | 0% | 100% | 1 |
6 | ADINAZOLAM SR | authKW | 102125 | 0% | 100% | 1 |
7 | ALPROZOLAM | authKW | 102125 | 0% | 100% | 1 |
8 | ANTIDEPRESSANT ANXIOLYTIC COMBINATION | authKW | 102125 | 0% | 100% | 1 |
9 | ASAHIGAOKA | address | 102125 | 0% | 100% | 1 |
10 | CGI SEVERITY INDEX | authKW | 102125 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 4502 | 44% | 0% | 132 |
2 | Pharmacology & Pharmacy | 2060 | 48% | 0% | 145 |
3 | Psychology, Clinical | 445 | 9% | 0% | 27 |
4 | Clinical Neurology | 193 | 12% | 0% | 37 |
5 | Medicine, General & Internal | 138 | 11% | 0% | 34 |
6 | Neurosciences | 115 | 14% | 0% | 41 |
7 | Psychology | 52 | 3% | 0% | 10 |
8 | Medicine, Research & Experimental | 44 | 6% | 0% | 17 |
9 | Primary Health Care | 25 | 1% | 0% | 3 |
10 | Chemistry, Medicinal | 17 | 3% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ASAHIGAOKA | 102125 | 0% | 100% | 1 |
2 | CLIN PHARMACEUT SCIENTIST PROGRAM | 102125 | 0% | 100% | 1 |
3 | DREP S PREVENT MED | 102125 | 0% | 100% | 1 |
4 | EXTRACORPORAL DETOXICAT CLIN | 102125 | 0% | 100% | 1 |
5 | KRANKENHAUS ROHRBACH THORAXERKRANKUNGEN KLIN | 102125 | 0% | 100% | 1 |
6 | DEP S PREVENT MED | 70697 | 1% | 23% | 3 |
7 | MARC MBRS UNDER PROGRAM | 51061 | 0% | 50% | 1 |
8 | STANLEY INNOVAT TREATMENT BIPOLAR DISORDER | 25530 | 0% | 25% | 1 |
9 | BAYC T GERIATR | 17019 | 0% | 17% | 1 |
10 | LEHRSTUHL INNERE MED GERONTOL | 17019 | 0% | 17% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTIVITAS NERVOSA SUPERIOR | 8626 | 3% | 1% | 9 |
2 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 8481 | 5% | 1% | 15 |
3 | JOURNAL OF CLINICAL PSYCHIATRY | 7616 | 8% | 0% | 23 |
4 | MINNESOTA MEDICINE | 5481 | 2% | 1% | 5 |
5 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2568 | 4% | 0% | 11 |
6 | PSYCHOPHARMACOLOGY BULLETIN | 2045 | 2% | 0% | 6 |
7 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1994 | 2% | 0% | 6 |
8 | MISSOURI MEDICINE | 1790 | 0% | 2% | 1 |
9 | PSYCHOPHARMACOLOGY | 1413 | 4% | 0% | 13 |
10 | HOMEOSTASIS IN HEALTH AND DISEASE | 1358 | 1% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | N DESMETHYLADINAZOLAM | 408498 | 1% | 100% | 4 | Search N+DESMETHYLADINAZOLAM | Search N+DESMETHYLADINAZOLAM |
2 | ADINAZOLAM | 357429 | 2% | 50% | 7 | Search ADINAZOLAM | Search ADINAZOLAM |
3 | SECOND PEAK PLASMA CONCENTRATIONS | 204249 | 1% | 100% | 2 | Search SECOND+PEAK+PLASMA+CONCENTRATIONS | Search SECOND+PEAK+PLASMA+CONCENTRATIONS |
4 | SIDE EFFECTS DRUG | 136165 | 1% | 67% | 2 | Search SIDE+EFFECTS+DRUG | Search SIDE+EFFECTS+DRUG |
5 | ADINAZOLAM DERACYN R | 102125 | 0% | 100% | 1 | Search ADINAZOLAM+DERACYN+R | Search ADINAZOLAM+DERACYN+R |
6 | ADINAZOLAM SR | 102125 | 0% | 100% | 1 | Search ADINAZOLAM+SR | Search ADINAZOLAM+SR |
7 | ALPROZOLAM | 102125 | 0% | 100% | 1 | Search ALPROZOLAM | Search ALPROZOLAM |
8 | ANTIDEPRESSANT ANXIOLYTIC COMBINATION | 102125 | 0% | 100% | 1 | Search ANTIDEPRESSANT+ANXIOLYTIC+COMBINATION | Search ANTIDEPRESSANT+ANXIOLYTIC+COMBINATION |
9 | CGI SEVERITY INDEX | 102125 | 0% | 100% | 1 | Search CGI+SEVERITY+INDEX | Search CGI+SEVERITY+INDEX |
10 | CLASSICAL BENZODIAZEPINES | 102125 | 0% | 100% | 1 | Search CLASSICAL+BENZODIAZEPINES | Search CLASSICAL+BENZODIAZEPINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN MARWIJK, H , ALLICK, G , WEGMAN, F , BAX, A , RIPHAGEN, II , (2012) ALPRAZOLAM FOR DEPRESSION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 7. P. - | 36 | 67% | 3 |
2 | JONAS, JM , COHON, MS , WEISSMAN , BARBEE, JG , KRAVITZ, HM , SHADER, RI , GREENBLATT , SELLERS, EM , SHEAR , (1993) A COMPARISON OF THE SAFETY AND EFFICACY OF ALPRAZOLAM VERSUS OTHER AGENTS IN THE TREATMENT OF ANXIETY, PANIC, AND DEPRESSION - A REVIEW OF THE LITERATURE.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 54. ISSUE . P. 25-48 | 39 | 60% | 48 |
3 | VERSTER, JC , VOLKERTS, ER , (2004) CLINICAL PHARMACOLOGY, CLINICAL EFFICACY, AND BEHAVIORAL TOXICITY OF ALPRAZOLAM: A REVIEW OF THE LITERATURE.CNS DRUG REVIEWS. VOL. 10. ISSUE 1. P. 45-76 | 63 | 24% | 51 |
4 | BIRKENHAGER, TK , MOLEMAN, P , NOLEN, WA , (1995) BENZODIAZEPINES FOR DEPRESSION - A REVIEW OF THE LITERATURE.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. VOL. 10. ISSUE 3. P. 181-195 | 29 | 63% | 38 |
5 | PETTY, F , TRIVEDI, MH , FULTON, M , RUSH, AJ , (1995) BENZODIAZEPINES AS ANTIDEPRESSANTS - DOES GABA PLAY A ROLE IN DEPRESSION.BIOLOGICAL PSYCHIATRY. VOL. 38. ISSUE 9. P. 578-591 | 30 | 56% | 80 |
6 | FLEISHAKER, JC , SMITH, TC , FRIEDMAN, H , PHILLIPS, JP , (1991) N-DESMETHYLADINAZOLAM PHARMACOKINETICS AND BEHAVIORAL-EFFECTS FOLLOWING ADMINISTRATION OF 10 50 MG ORAL DOSES IN HEALTHY-VOLUNTEERS.PSYCHOPHARMACOLOGY. VOL. 105. ISSUE 2. P. 181-185 | 15 | 88% | 4 |
7 | VONVOIGTLANDER, PF , STRAW, RN , (1985) ALPRAZOLAM - REVIEW OF PHARMACOLOGICAL, PHARMACOKINETIC, AND CLINICAL-DATA.DRUG DEVELOPMENT RESEARCH. VOL. 6. ISSUE 1. P. 1-12 | 24 | 73% | 22 |
8 | FLEISHAKER, JC , WRIGHT, CE , (1992) PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF IMMEDIATE-RELEASE AND SUSTAINED-RELEASE ADINAZOLAM MESYLATE TABLETS AFTER SINGLE-DOSE AND MULTIPLE-DOSE ADMINISTRATION.PHARMACEUTICAL RESEARCH. VOL. 9. ISSUE 4. P. 457-463 | 14 | 88% | 6 |
9 | FLEISHAKER, JC , SISSON, TA , SRAMEK, JJ , CONRAD, J , VEROFF, AE , CUTLER, NR , (1993) PSYCHOMOTOR AND MEMORY EFFECTS OF 2 ADINAZOLAM FORMULATIONS ASSESSED BY A COMPUTERIZED NEUROPSYCHOLOGICAL TEST BATTERY.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 33. ISSUE 5. P. 463-469 | 14 | 82% | 4 |
10 | FLEISHAKER, JC , HULST, LK , SMITH, TC , FRIEDMAN, H , (1992) CLINICAL-PHARMACOLOGY OF ADINAZOLAM AND N-DESMETHYLADINAZOLAM MESYLATE FOLLOWING SINGLE INTRAVENOUS INFUSIONS OF EACH COMPOUND IN HEALTHY-VOLUNTEERS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 42. ISSUE 3. P. 287-294 | 12 | 100% | 5 |
Classes with closest relation at Level 1 |